Lichen International Limited
LICN
$3.12
-$0.13-4.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -10.23% | -3.15% | 4.32% | 13.73% | 24.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.23% | -3.15% | 4.32% | 13.73% | 24.86% |
| Cost of Revenue | -0.82% | 0.72% | 2.36% | 9.76% | 17.95% |
| Gross Profit | -16.31% | -5.62% | 5.57% | 16.38% | 29.78% |
| SG&A Expenses | 128.63% | 138.66% | 150.60% | 86.14% | 20.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.45% | 63.18% | 67.37% | 44.04% | 19.23% |
| Operating Income | -203.52% | -168.69% | -137.12% | -67.19% | 43.69% |
| Income Before Tax | -234.20% | -184.27% | -136.00% | -62.08% | 61.18% |
| Income Tax Expenses | -70.01% | -55.49% | -40.06% | 0.86% | 64.01% |
| Earnings from Continuing Operations | -307.40% | -237.94% | -173.40% | -87.65% | 59.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -309.89% | -239.26% | -173.63% | -87.79% | 59.95% |
| EBIT | -203.52% | -168.69% | -137.12% | -67.19% | 43.69% |
| EBITDA | -170.07% | -144.43% | -118.71% | -51.21% | 49.06% |
| EPS Basic | -217.30% | -180.18% | -146.62% | -73.58% | 37.52% |
| Normalized Basic EPS | -176.64% | -148.07% | -121.59% | -57.54% | 37.26% |
| EPS Diluted | -217.30% | -180.18% | -146.62% | -73.58% | 37.52% |
| Normalized Diluted EPS | -176.64% | -148.07% | -121.59% | -57.54% | 37.26% |
| Average Basic Shares Outstanding | 60.63% | 52.52% | 43.11% | 34.74% | 25.68% |
| Average Diluted Shares Outstanding | 60.63% | 52.52% | 43.11% | 34.74% | 25.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |